Cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: diagnostic and prognostic value

Cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: diagnostic and prognostic value

Imaging techniques currently play a key role in cardiovascular assessing. Cardiac magnetic resonance imaging (MRI) is one the main elements of diagnosis and prognostic significance of hypertrophic cardiomyopathy (HCMP). The article provides a brief overview on both conventional and novel areas of MR...

Full description

Bibliographic Details
Main Authors:	S. V. Shayakhmetova, V. E. Sinitsyn, A. V. Afanasyev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2019-12-01
Series:	Российский кардиологический журнал
Subjects:	hypertrophic cardiomyopathy magnetic resonance imaging left ventricle myectomy
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3613

Similar Items

Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy
by: Binita Riya Chacko, et al.
Published: (2018-01-01)

Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy
by: Xiangbin Meng, et al.
Published: (2020-05-01)

Hypertrophic cardiomyopathy part II - Anesthetic and surgical considerations
by: Praveen Kerala Varma, et al.
Published: (2014-01-01)

The modern approach to the treatment of diffuse - generalized forms of hypertrophic cardiomyopathy in the cardiac surgery
by: A. N. Shapieva, et al.
Published: (2016-02-01)

Transapical Approach to Septal Myectomy for Hypertrophic Cardiomyopathy
by: Alexander Afanasyev, et al.
Published: (2024-01-01)

MYOCARDIAL REMODELLING TYPES IN HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY
by: D. V. Bogdanov
Published: (2015-05-01)

Resection of hypertrophic papillary muscles and mitral valve replacement in a patient with midventricular hypertrophic obstructive cardiomyopathy – a new approach
by: Julian J. Berg, et al.
Published: (2024-02-01)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
by: Felice Gragnano, et al.
Published: (2023-04-01)

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
by: A. G. Osiev, et al.
Published: (2016-02-01)

Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy
by: Sergei A. Budagaev, et al.
Published: (2023-07-01)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
by: Cristian Izquierdo, et al.
Published: (2021-10-01)

Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy?
by: Elnur Alizade, et al.
Published: (2018-05-01)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
by: Barry J. Maron, et al.
Published: (2022-05-01)

Cardiac Myosin Inhibitors as a Novel Treatment Option for Obstructive Hypertrophic Cardiomyopathy: Addressing the Core of the Matter
by: Ahmad Masri, et al.
Published: (2022-05-01)

Surgical septal myectomy versus septal alcohol ablation for hypertrophic obstructive cardiomyopathy: a continuing debate
by: S Meditskou, et al.
Published: (2008-05-01)

Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
by: Victor Arévalos, et al.
Published: (2021-05-01)

Surgical Myectomy after Failed Ablation for Hypertrophic Obstructive Cardiomyopathy
by: Ioannis Bougioukas, et al.
Published: (2016-04-01)

Hypertrophic Cardiomyopathy in Elderly Individuals: Is It a Rose by Another Name?
by: Deacon Z. J. Lee, et al.
Published: (2021-02-01)

Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review
by: Steven Lebowitz, et al.
Published: (2022-06-01)

CHARACTERISTICS AND RESULTS OF A SURGICAL TREATMENT OF PATIENTS WITH A HYPERTROPHIC CARDIOMYOPATHY
by: Zh.N. Nurbay, et al.
Published: (2022-06-01)

CHARACTERISTICS AND RESULTS OF A SURGICAL TREATMENT OF PATIENTS WITH A HYPERTROPHIC CARDIOMYOPATHY
by: Zh.N. Nurbay, et al.
Published: (2022-06-01)

Plasma metabolomic profiling of hypertrophic cardiomyopathy patients before and after surgical myectomy suggests postoperative improvement in metabolic function
by: Nicole L. Wolter, et al.
Published: (2021-12-01)

Minimally Invasive Trans-Mitral Septal Myectomy to Treat Hypertrophic Obstructive Cardiomyopathy
by: Hong Rae Kim, et al.
Published: (2015-12-01)

Diagnosis of a rare combination of hypertrophic and left ventricular noncompaction cardiomyopathy using cardiac magnetic resonance imaging
by: Sinem Özyılmaz, et al.
Published: (2016-07-01)

ATRIAL FIBRILLATION AND FLUTTER IN HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2015-05-01)

Long-term outcomes of surgery for obstructive hypertrophic cardiomyopathy in a pediatric cohortCentral MessagePerspective
by: Stephanie N. Nguyen, MD, et al.
Published: (2023-12-01)

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy
by: Tolga Aksu, et al.
Published: (2017-01-01)

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
by: Xiangbin Meng, et al.
Published: (2022-03-01)

Perioperative Amiodarone to Prevent Atrial fibrillation after Septal Myectomy in obstrUctive hypeRtroPHic cardiomyopathy
by: Evan F. Shalen, et al.
Published: (2021-12-01)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
by: Ethan J. Rowin, et al.
Published: (2019-11-01)

Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
by: Ibadete Bytyçi, et al.
Published: (2020-09-01)

Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation
by: Amy Larson, et al.
Published: (2021-03-01)

Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy
by: Hong-Chang Guo, et al.
Published: (2018-01-01)

Septal Myectomy and Subvalvular Repair in Hypertrophic Cardiomyopathy, a Systematic Review and Pooled Analysis
by: Ming-Yang Song, et al.
Published: (2023-09-01)

Maintenance of Subcutaneous Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy Patients With Iatrogenic Left Bundle‐Branch Block After Septal Myectomy
by: Chockalingam A. Narayanan, et al.
Published: (2024-04-01)

Improvement in coronary microvascular dysfunction evaluated by cardiac magnetic resonance in patients with hypertrophic obstructive cardiomyopathy after transapical beating-heart septal myectomy
by: Yun Zhao, et al.
Published: (2023-10-01)

Left Ventricular Enlargement Procedure in a Patient with Diffuse-Type Hypertrophic Cardiomyopathy: A Case Report
by: Dong Youb Han, et al.
Published: (2022-04-01)

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
by: Alexandru Achim, et al.
Published: (2023-06-01)

Hypertrophic Cardiomyopathy
by: Polakit Teekakirikul, MD, et al.
Published: (2021-09-01)

Relationship between electrocardiographic findings and Cardiac Magnetic Resonance phenotypes in patients with Hypertrophic Cardiomyopathy
by: Matteo Fronza, et al.
Published: (2016-06-01)